Artificial Intelligence - Catch up on select AI news and developments from the past week or so. Stay in the know.

Poetiq was launched last year by former Google DeepMind researchers Shumeet Baluja and Ian Fischer. Baluja established the Alphabet unit’s computer vision group, while Fischer helped develop some of ...

Out of all the tools available to home labbers, I think local DNS servers are the most powerful. I've used many variants, from PowerDNS to Technitium, Unbound, BIND9, and CoreDNS, each with its own ...

Ad-free internet is no-longer a subscription you have to pay for.

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

What works in controlled agentic AI demos often breaks down at scale, where integration, reliability, security, governance and performance expectations are far higher.

RXRX has reported updated data from its ELUCIDATE and TUPELO trials, but the stock has failed to mount a sustained rally. The ELUCIDATE update provides just an additional 10 patients of data treated ...

Popular market commentator and TV personality Jim Cramer made a rather dramatic plea to Strategy Inc. (NASDAQ:MSTR) Chair Michael Saylor on Tuesday, urging him to act and stop Bitcoin’s (CRYPTO: BTC) ...

AI agents are powerful, but without a strong control plane and hard guardrails, they’re just one bad decision away from chaos.

Economist Peter Schiff questioned on Thursday how Strategy Inc. (NASDAQ:MSTR) can sustain the 11% dividend payout on its ...